Eribulin Advanz Pharma

Eribulin Mesylate is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer treatment.

Eribulin Mesylate is primarily used in the treatment of metastatic breast cancer. It is administered intravenously and is often considered when other treatments have not been effective. This medication targets cancer cells to inhibit their growth and spread.

Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some individuals may also experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. These effects vary among patients and should be discussed with a healthcare provider.

Eribulin Mesylate should be handled with care, as it is a potent chemotherapy agent. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Patients should be monitored regularly for any adverse reactions.

Eribulin Mesylate may interact with other medications, including those that affect liver function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this drug.